Search Course Outline

Showing 25 course outlines from 2702 matches

776

MEDSCI 317

: Integrative Neuroscience: From Fetus to Adult
2024 Semester Two (1245)
The development and function of the central nervous system in health and disease. Topics include development of the CNS, functional imaging of the human brain, synaptic function in health and disease, development and pathophysiology of motor systems, perinatal and adult brain ischemia, stroke, and sleep related disorders. The topics are covered at an advanced level with emphasis on current advances in the fields.
Subject: Medical Science
Prerequisite: MEDSCI 206
777

MEDSCI 317

: Integrative Neuroscience: From Fetus to Adult
2023 Semester Two (1235)
The development and function of the central nervous system in health and disease. Topics include development of the CNS, functional imaging of the human brain, synaptic function in health and disease, development and pathophysiology of motor systems, perinatal and adult brain ischemia, stroke, and sleep related disorders. The topics are covered at an advanced level with emphasis on current advances in the fields.
Subject: Medical Science
Prerequisite: MEDSCI 206
778

MEDSCI 317

: Integrative Neuroscience: From Fetus to Adult
2022 Semester Two (1225)
The development and function of the central nervous system in health and disease. Topics include development of the CNS, functional imaging of the human brain, synaptic function in health and disease, development and pathophysiology of motor systems, perinatal and adult brain ischemia, stroke, and sleep related disorders. The topics are covered at an advanced level with emphasis on current advances in the fields.
Subject: Medical Science
Prerequisite: MEDSCI 206
779

MEDSCI 317

: Integrative Neuroscience: From Fetus to Adult
2021 Semester Two (1215)
The development and function of the central nervous system in health and disease. Topics include development of the CNS, functional imaging of the human brain, synaptic function in health and disease, development and pathophysiology of motor systems, perinatal and adult brain ischemia, stroke, and sleep related disorders. The topics are covered at an advanced level with emphasis on current advances in the fields.
Subject: Medical Science
Prerequisite: MEDSCI 206
780

MEDSCI 317

: Integrative Neuroscience: From Fetus to Adult
2020 Semester Two (1205)
The development and function of the central nervous system in health and disease. Topics include development of the CNS, functional imaging of the human brain, synaptic function in health and disease, development and pathophysiology of motor systems, perinatal and adult brain ischemia, stroke, and sleep related disorders. The topics are covered at an advanced level with emphasis on current advances in the fields.
Subject: Medical Science
Prerequisite: MEDSCI 206
781

MEDSCI 318

: Pharmacokinetics and Drug Toxicity
2025 Semester One (1253)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
782

MEDSCI 318

: Pharmacokinetics and Drug Toxicity
2024 Semester One (1243)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
783

MEDSCI 318

: Pharmacokinetics and Drug Toxicity
2023 Semester One (1233)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
784

MEDSCI 318

: Pharmacokinetics and Drug Toxicity
2022 Semester One (1223)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
785

MEDSCI 318

: Pharmacokinetics and Drug Toxicity
2021 Semester One (1213)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
786

MEDSCI 319

: Molecular Pharmacology
2025 Semester One (1253)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
787

MEDSCI 319

: Molecular Pharmacology
2024 Semester One (1243)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
788

MEDSCI 319

: Molecular Pharmacology
2023 Semester One (1233)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
789

MEDSCI 319

: Molecular Pharmacology
2022 Semester One (1223)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
790

MEDSCI 319

: Molecular Pharmacology
2021 Semester One (1213)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
791

MEDSCI 320

: Pharmacology of the Brain and Body
2025 Semester Two (1255)
Extends the principles of pharmacology acquired at Stage II to discuss how diseases can be treated in a variety of organ systems including the cardiovascular, gastrointestinal, endocrine, reproductive, and respiratory systems with emphasis on the central nervous system. Covers the mechanisms of action of drugs, and the influence of anatomy, physiology and pathology.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, 206, BIOSCI 203
Restriction: MEDSCI 305, 307
792

MEDSCI 320

: Pharmacology of the Brain and Body
2024 Semester Two (1245)
Extends the principles of pharmacology acquired at Stage II to discuss how diseases can be treated in a variety of organ systems including the cardiovascular, gastrointestinal, endocrine, reproductive, and respiratory systems with emphasis on the central nervous system. Covers the mechanisms of action of drugs, and the influence of anatomy, physiology and pathology.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, 206, BIOSCI 203
Restriction: MEDSCI 305, 307
793

MEDSCI 320

: Pharmacology of the Brain and Body
2023 Semester Two (1235)
Extends the principles of pharmacology acquired at Stage II to discuss how diseases can be treated in a variety of organ systems including the cardiovascular, gastrointestinal, endocrine, reproductive, and respiratory systems with emphasis on the central nervous system. Covers the mechanisms of action of drugs, and the influence of anatomy, physiology and pathology.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, 206, BIOSCI 203
Restriction: MEDSCI 305, 307
794

MEDSCI 320

: Pharmacology of the Brain and Body
2022 Semester Two (1225)
Extends the principles of pharmacology acquired at Stage II to discuss how diseases can be treated in a variety of organ systems including the cardiovascular, gastrointestinal, endocrine, reproductive, and respiratory systems with emphasis on the central nervous system. Covers the mechanisms of action of drugs, and the influence of anatomy, physiology and pathology.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, 206, BIOSCI 203
Restriction: MEDSCI 305, 307
795

MEDSCI 320

: Pharmacology of the Brain and Body
2021 Semester Two (1215)
Extends the principles of pharmacology acquired at Stage II to discuss how diseases can be treated in a variety of organ systems including the cardiovascular, gastrointestinal, endocrine, reproductive, and respiratory systems with emphasis on the central nervous system. Covers the mechanisms of action of drugs, and the influence of anatomy, physiology and pathology.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, 206, BIOSCI 203
Restriction: MEDSCI 305, 307
796

MEDSCI 321

: Special Topic: Concepts in Pharmacology
2022 Semester One (1223)
Explores the cellular and molecular mechanisms of drug action plus drug discovery and development from the perspective of in silico modelling, biochemical assessment, intracellular signalling and human disease. Considers the pharmacokinetic processes of input, distribution and elimination involved in achieving clinically-relevant drug concentrations. Describes the link between concentration and effect and the time course of effect. Explores factors such as disease progression, drug metabolism, drug-drug interactions, pharmacogenetics, use in selected populations and in various pathological conditions that may influence both clinical effectiveness and drug toxicity.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from BIOSCI 203, MEDSCI 203, 205
Restriction: MEDSCI 303, 306, 318, 319, 735
797

MEDSCI 700

: Drug Discovery Biology
2025 Semester One (1253)
Reviews recent studies on the use of chemical and genetic methods to characterise the role of proteins in disease and their potential as drug targets. Topics will include proteins involved in regulation of immune response, lipid mediated cell signalling pathways, drug-protein interactions, some discovery methods, and pre-clinical studies on mechanism of action.
Subject: Medical Science
No pre-requisites or restrictions
798

MEDSCI 700

: Drug Discovery Biology
2024 Semester One (1243)
Reviews recent studies on the use of chemical and genetic methods to characterise the role of proteins in disease and their potential as drug targets. Topics will include proteins involved in regulation of immune response, lipid mediated cell signalling pathways, drug-protein interactions, some discovery methods, and pre-clinical studies on mechanism of action.
Subject: Medical Science
No pre-requisites or restrictions
799

MEDSCI 700

: Drug Discovery Biology
2023 Semester One (1233)
Reviews recent studies on the use of chemical and genetic methods to characterise the role of proteins in disease and their potential as drug targets. Topics will include proteins involved in regulation of immune response, lipid mediated cell signalling pathways, drug-protein interactions, some discovery methods, and pre-clinical studies on mechanism of action.
Subject: Medical Science
No pre-requisites or restrictions
800

MEDSCI 700

: Drug Discovery Biology
2021 Semester One (1213)
Reviews recent studies on the use of chemical and genetic methods to characterise the role of proteins in disease and their potential as drug targets. Topics will include proteins involved in regulation of immune response, lipid mediated cell signalling pathways, drug-protein interactions, some discovery methods, and pre-clinical studies on mechanism of action.
Subject: Medical Science
No pre-requisites or restrictions